Company
Zymeworks Inc.
Headquarters: Vancouver, BC, Canada
Founded: 2003
Employees: 455
CEO: Mr. Kenneth H. Galbraith C.A.
Market Cap
$976.0 Million
USD as of July 1, 2025
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $309.91 B |
| Vertex Pharmaceuticals Incorporated | $117.36 B |
| CSL Limited | $95.75 B |
| Regeneron Pharmaceuticals, Inc. | $59.14 B |
| Marinomed Biotech AG | $58.56 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Detailed Description
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas, breast, and colorectal cancer; and ZW49, a biparatopic anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate that is in Phase 1 clinical trial for the treatment of advanced or metastatic HER2-expressing tumors. The company has strategic partnerships with Merck Sharp & Dohme Research Ltd.; Eli Lilly and Company; Bristol-Myers Squibb company; GlaxoSmithKline Intellectual Property Development Ltd.; Daiichi Sankyo Co., Ltd.; Janssen Biotech, Inc.; BeiGene, Ltd.; and Exelixis, Inc. It also has licensing and research collaboration with LEO Pharma A/S to research, develop, and commercialize bispecific antibodies; and Iconic Therapeutics, Inc. Zymeworks Inc. was incorporated in 2003 and is headquartered in Vancouver, Canada.
Financials
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | $93.4 M |
| EBITDA | $-99,293,000 |
| Gross Profit TTM | $-46,111,000 |
| Profit Margin | -121.73% |
| Operating Margin | -94.48% |
| Quarterly Revenue Growth | 170.30% |
Stocks & Indices
Zymeworks Inc. has the following listings and related stock indices.
Stock: NYSE: ZYME wb_incandescent
Stock: FSX: 0OX wb_incandescent
Product & Services
Pharmaceuticals
Key People
Ali Tehrani Donald L. Drakeman